|
Feb 20
|
Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus
|
|
Feb 20
|
FibroGen to Sell China Unit to AstraZeneca for $160 Million
|
|
Feb 20
|
Here’s Why AstraZeneca PLC (AZN) Traded Lower in Q4
|
|
Feb 20
|
AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal
|
|
Feb 20
|
AstraZeneca deepens China presence with FibroGen deal
|
|
Feb 20
|
Q4 2024 Ionis Pharmaceuticals Inc Earnings Call
|
|
Feb 20
|
Luxury hotels group Firmdale has sold 20% stake to Swedish pharma tycoon
|
|
Feb 20
|
AstraZeneca Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Feb 18
|
AstraZeneca boss takes home £15m pay packet after profits rise
|
|
Feb 18
|
AstraZeneca (LON:AZN) Is Posting Promising Earnings But The Good News Doesn’t Stop There
|
|
Feb 17
|
AstraZeneca’s Imfinzi bladder cancer regimen improves survival in Phase III trial
|
|
Jan 6
|
Why Is AstraZeneca PLC (NASDAQ:AZN) Among the Best FTSE Dividend Stocks to Buy Now?
|
|
Jan 6
|
AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?
|
|
Jan 4
|
Better Buy: Novo Nordisk vs. AstraZeneca
|
|
Jan 3
|
China’s NMPA prioritises HUTCHMED’s lung cancer therapy review
|
|
Jan 3
|
The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer
|
|
Jan 2
|
MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN
|
|
Jan 2
|
5 Large Drug Stocks to Keep An Eye On in the New Year
|